Improved Quality of Life in Unselected Insulin Pump-Treated Children with Type 1 Diabetes in Eastern Nebraska
| Autor: | William Austin, Sara R. Rendell, Marc Rendell, Apoorva Sharma, Greg Penny, Omofosolade Kosoko-Lasaki, Cynthia T. Cook |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Insulin pump
Pediatrics medicine.medical_specialty Type 1 diabetes business.industry Endocrinology Diabetes and Metabolism Insulin medicine.medical_treatment Biomedical Engineering Bioengineering medicine.disease Letter to Editor Quality of life Diabetes mellitus Statistical significance Internal Medicine medicine Health insurance Rural area business |
| Zdroj: | Journal of Diabetes Science and Technology. 7:579-581 |
| ISSN: | 1932-2968 |
| DOI: | 10.1177/193229681300700235 |
| Popis: | Continuous subcutaneous insulin infusion (CSII) via pump injectors first became a treatment option for patients with type 1 diabetes in the 1970s and has had increasing use. Several studies have demonstrated a clinically important improvement in hemoglobin A1c levels and a reduction in blood glucose variability as well as in hypoglycemic episodes in patients treated with CSII as compared with multiple daily injections (MDI).1–3 Several studies that explored quality of life (QOL) suggested that patients undergoing CSII are significantly more satisfied with treatment than those receiving MDI.4–10 These studies have used prospective comparisons in defined groups, typically from a single research center during the transition of patients to insulin pump therapy, thus representing potentially biased samples. There is little information about the QOL perceptions of insulin pump therapy in unselected children with type 1 diabetes in a community setting.11–15 We used a World Health Organization survey instrument that was modified and adapted to address areas related specifically to diabetes, using the Community Assessment Instrument Pre-Test 17 and WHOQOL-BREF16 at Camp Floyd Rogers, a 1-week summer camp for children with diabetes (ages 8–18 years old). The camp is located in Eastern Nebraska, a region that encompasses both urban and rural areas, thereby providing an unselected community sample. Fifty-three children (33 females and 20 males) participated in the survey. Their ages ranged from 9 to 17 years old, with an average age of 12.6 ± 2.2 for all participants. More children used pumps (34) as compared with those who received conventional injections.17 Thirty-three of the 34 children in the CSII group were European American, and 1 child was African American. The conventional group included 1 Native American child, 2 Latino children, and 1 African American child. The results are summarized in Table 1. Comparisons between the insulin pump group and the conventional injection group were most remarkable because of the lack of significant separation of variables. The two groups were comparable in parental education, frequency of intensive glucose testing (75–80%), visits to an endocrinologist and ophthalmologist; emergency room visits, and hospitalizations. The families of insulin pump users did have a moderately higher overall income, but health insurance was equivalent. The difference in average hemoglobin A1c in the insulin pump-treated children (8.1 ± 0.2) as compared with that of the conventional insulin group (8.8 ± 0.5) did not reach statistical significance. Table 1 Comparison of Diabetes Care in Insulin Pump-Treated Children and Those Receiving Multiple Daily Injectionsa |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|